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Nallet-Staub et al. demonstrate cell-type-
specific inhibition of TGF-b signaling by
cell-cell contacts, restricted to polarized
epithelial cells. The latter undergo strict
density-dependent basolateral
redistribution of TGF-b receptors that
prevents apical TGF-b signaling. Cell-cell
contact-driven Hippo pathway activation
is ubiquitous and does not interfere with
TGF-b signaling.
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Cell-cell contacts inhibit cell growth and proliferation
in part by activating theHippopathway that drives the
phosphorylation and nuclear exclusion of the tran-
scriptional coactivators YAP and TAZ. Cell density
andHippo signaling have also been reported to block
transforming growth factor b (TGF-b) responses,
based on the ability of phospho-YAP/TAZ to
sequester TGF-b-activated SMAD complexes in the
cytoplasm. Herein, we provide evidence that epithe-
lial cell polarization interferes with TGF-b signaling
well upstream and independent of cytoplasmic
YAP/TAZ. Rather, polarized basolateral presentation
of TGF-b receptors I and II deprives apically delivered
TGF-b of access to its receptors. Basolateral ligand
delivery nonetheless remains entirely effective to
induce TGF-b responses. These data demonstrate
that cell-type-specific inhibition of TGF-b signaling
by cell density is restricted topolarized epithelial cells
and reflects the polarized distribution of TGF-b re-
ceptors, which thus affects SMAD activation irre-
spective of Hippo pathway activation.
INTRODUCTION
Cell-cell contacts drive signals controlling the process of contact
inhibition, a phenomenon whereby normal cells grown in mono-
layers exhibit reduced proliferation, even growth arrest, when
reaching confluency. This property is often lost during neoplastic
progression or in vitro transformation. Recently, clues regarding
the mechanisms by which cells sense contacts with other cells
have emerged. In particular, the Hippo pathway, originally iden-
tified as a mechanism controlling organ size in Drosophila via
inhibition of cell proliferation and induction of apoptosis, was
identified as a major player in this process (Zhao et al., 2007).
Specifically, it was found that activation of Hippo signaling by
cell density sensing leads to phosphorylation and nuclear exclu-640 Developmental Cell 32, 640–651, March 9, 2015 ª2015 Elseviersion of its effector molecules YAP and TAZ, thereby restraining
the nuclear activity of the latter, which otherwise act as co-tran-
scriptional activators of TEAD and other transcription factors to
promote cell proliferation. In polarized cells, the apical-basal
cell polarity determinant Crumbs was found to directly regulate
Hippo signaling, and thus YAP/TAZ nucleo-cytoplasmic localiza-
tion and function (Chen et al., 2010; Robinson et al., 2010).
Remarkably, YAP and TAZ may also undergo nuclear exclusion
upon mechanical stress induced by extracellular matrix rigidity
and cell geometry, in a process requiring Rho GTPase signaling
and the actomyosin cytoskeleton, independent from Hippo ac-
tivity (Dupont et al., 2011).
Various mechanisms have been described whereby the Hippo
pathway and/or its effectors YAP/TAZ interfere with the trans-
forming growth factor beta (TGF-b)/SMAD cascade (Mauviel
et al., 2012). We initially identified YAP as a SMAD7-interacting
protein that cooperates with the latter to block TGF-b receptor
type I (TbRI) function, thereby inhibiting TGF-b signaling (Fer-
rigno et al., 2002). In Drosophila, Yorkie (YAP homolog) was
found to bind and potentiate Mad (SMAD homolog)-driven tran-
scription (Alarco´n et al., 2009; Oh and Irvine, 2011), while in
mammalian cells, it was found that YAP and TAZ are required
for efficient nuclear translocation and transcriptional activity of
SMAD complexes in response to TGF-b (Varelas et al., 2008).
The same authors also described a mechanism whereby phos-
phorylated YAP and TAZ, excluded from the cell nucleus upon
cell-cell contacts, sequester active SMAD complexes in the
cytoplasm, thereby suppressing cellular responses to TGF-b in
cells grown at high density (Varelas et al., 2010). The latter find-
ings suggest that confluent cells are not responsive to TGF-b, at
odds with a large body of literature on TGF-b. Indeed, in the early
days of TGF-b research, the use of dense, confluent cell cultures
was often preferred to better understand the broad capacity of
TGF-b to regulate gene expression and/or differentiation. For
example, confluent skin, gingival or lung fibroblasts (Chung
et al., 1996; Daniels et al., 2004; Mauviel et al., 1994; Wrana
et al., 1991), keratinocytes (Kon et al., 1999; Mauviel et al.,
1996), chondrocytes (Redini et al., 1991), and/or calvarial bone
cells (Wrana et al., 1988), to cite a few, all respond to TGF-b
with increased or decreased expression of fibrillar and non-
fibrillar collagens (Chung et al., 1996; Kon et al., 1999; MauvielInc.
Figure 1. Impact of Cell Density on TGF-b Signaling
HaCaT keratinocytes, 1205Lu melanoma cells, and EpH4 mouse mammary
epithelial cells were grown in either low (LD) or high (HD) density conditions
prior to TGF-b (5 ng/ml) stimulation.
(A) Quantitative RT-PCR analysis of PAI-1 expression after a 24-hr TGF-b
treatment. Results are expressed as -fold induction by TGF-b in each culture
condition and are the mean ± SD from three independent experiments, each
measured in triplicate.
(B) Effect of TGF-b on SMAD3/4-specific transcription. Results are expressed
as -fold activation of transiently transfected (CAGA)9-MLP-luc activity 18 hr
after TGF-b addition to the cultures. Results are the mean ± SD of two inde-
pendent experiments, each performed with triplicate samples.
(C) Western analysis of P-SMAD3 levels without () or with (+) 30 min TGF-b
stimulation. Actin levels were measured as a control for the specificity of P-
SMAD3 changes under each experimental condition. Results from one
representative of several independent experiments are shown.et al., 1994), fibronectin (Daniels et al., 2004; Ignotz et al., 1989),
SPARC (Wrana et al., 1991), laminins (Korang et al., 1995), integ-
rins (Heino and Massague´, 1989), proteoglycans (Redini et al.,
1991), metalloproteinases and protease inhibitors such as plas-
minogen activator inhibitor 1 (PAI-1) or tissue inhibitor of metal-
loproteases (Mauviel et al., 1996; Overall et al., 1989). Likewise,
early-response genes are efficiently induced by TGF-b in
confluent skin fibroblasts and keratinocytes (Mauviel et al.,
1993, 1996). The broad ability of TGF-b to control the turnoverDevelof extracellular matrix and cell adhesion molecules largely con-
tributes to its capacity to orchestrate tissue homeostasis and
function, to promote tissue repair, epithelial-to-mesenchymal
transition (EMT), and to mediate tissue fibrosis when signaling
is deregulated and excessive.
Given the conflicting results from the literature pertaining to an
important aspect of TGF-b biology (i.e., interference or not of
cell-cell contacts with TGF-b signaling), we undertook a broad
examination of TGF-b responses as a function of cell density in
a variety of cell types. Our results demonstrate that cell con-
tact-induced nuclear exclusion of Hippo effectors YAP and
TAZ does not interfere with TGF-b responses, measured as
SMAD3 phosphorylation, nuclear translocation, and gene acti-
vation. Rather, loss of TGF-b responsiveness in dense cell cul-
tures is independent of cell density per se, and appears to be
restricted to polarized epithelial cells that undergo a remarkable
cell density-dependent shift in TGF-b receptor (TbR) localization
from pericellular at low cell density to exclusively basolateral at
high cell density when tight cell-cell contacts are established.
This domain-specific receptor localization, in turn, prevents
SMAD phosphorylation and associated gene responses from
apically delivered TGF-b ligand, while TGF-b signaling is fully effi-
cient when initiated from the basolateral sides of polarized cells.
These results shed new light on the relationship between cellular
density and TGF-b responses, independent from the nucleo-
cytoplasmic shuttling of Hippo pathway effectors.
RESULTS
In Most Cell Types, Cell Density Does Not Inhibit TGF-b
Responses
We first examined how cell density affects TGF-b signaling in
various cell lines from distinct lineages that have classically
been used for TGF-b signaling studies, including HaCaT kerati-
nocytes (Alarco´n et al., 2009; Gomis et al., 2006; Levy and Hill,
2005; Reynisdo´ttir et al., 1995), 1205Lu and other human mela-
noma cell lines extensively characterized for functional SMAD
signaling implicated in their invasive and metastatic potential
(Alexaki et al., 2010; Javelaud et al., 2007; Mohammad et al.,
2011; Rodeck et al., 1999), human pancreatic PANC-1 (Dennler
et al., 2007; Ellenrieder et al., 2001; Nicola´s and Hill, 2003) and
breast MDA-MB-231 carcinoma cells (Kang et al., 2003; Yin
et al., 1999), as well as mouse mammary epithelial EpH4 cells
(Varelas et al., 2010). As shown in Figures 1 and S1, in all but
EpH4 cells, there was no remarkable attenuation in the extent
of TGF-b-induced expression of the prototypic target gene
PAI-1 (Figures 1A and S1A) or activity of a SMAD3/4-specific re-
porter in transient cell transfection assays (Figures 1B and S1B).
In fact, the extent of PAI-1 induction by TGF-bwas even higher in
HaCaT and 1205Lu cells grown at high density than in prolifer-
ating sparse cells.
The primary signaling event downstream of activated TGF-b
receptors is SMAD3 phosphorylation. Remarkably, in dense
EpH4 mouse mammary cell cultures, reduction in SMAD-spe-
cific transcription and target gene activation in response to
TGF-b was associated with an almost complete lack of
SMAD3 phosphorylation (Figure 1C), which was not affected
by cell density in any of the other five cell lines that were exam-
ined (Figures 1C and S1C).opmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevier Inc. 641
Figure 2. Independent Regulation of SMAD2/3 Nuclear Translocation and Density-Dependent TAZ Nucleo-Cytoplasmic Localization
(A–C) Simultaneous detection of SMAD2/3 and TAZ in HaCaT keratinocytes (A), 1205Lu melanoma cells (B), and EpH4 mouse mammary epithelial cells (C). Cells
were grown on glass coverslips in either low (LD) or high (HD) density conditions prior to TGF-b (30 min, 5 ng/ml) stimulation, then subjected to simultaneous
immunofluorescent detection of SMAD2/3 (green) and TAZ (red). Experiments were repeated four to six times, depending on cell line.Nuclear Translocation of SMAD2/3 in Response to TGF-
b Is Independent fromTAZNuclear Exclusion Inducedby
Cell Density
The previous data contrast with the report showing that TGF-b
induces SMAD3 phosphorylation in confluent EpH4 cells (Vare-
las et al., 2010). Since Hippo pathway activation has been iden-
tified as a sensor for cell-cell contacts (Zhao et al., 2007),
together with the fact that phosphorylation of SMAD3 is a pre-
requisite for its nuclear accumulation and subsequent gene re-
sponses, TAZ and SMAD2/3 nucleo-cytoplasmic localization
were studied in parallel by indirect immunofluorescence in642 Developmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevierseveral cell types grown at low or high density, in the absence
or presence of TGF-b. As shown in Figure 2A, HaCaT cells
grown at low density exhibited both cytoplasmic and nuclear
TAZ, while high-density cultures exhibited remarkable nuclear
exclusion of TAZ, (red fluorescence), independent from
TGF-b. Parallel examination of SMAD2/3 localization following
a 30-min TGF-b stimulation of HaCaT cells grown at low or
high density indicated strong nuclear accumulation of
P-SMAD3 in response to TGF-b, whether at low or high density
(Figure 2A, green fluorescence), without changes in TAZ local-
ization in response to TGF-b. Similar results were obtained inInc.
1205Lu cells (Figure 2B). Thus, in these two cell types, nuclear
accumulation of P-SMAD3 occurs in response to TGF-b
despite TAZ nuclear exclusion resulting from cell density
sensing, indicating that the two proteins are able to indepen-
dently shuttle between the cytoplasm and nucleus. Quantitation
of nuclear SMAD3 and TAZ in these three cell lines at high cell
density in absence or presence of TGF-b is provided in Fig-
ure S2A. Consistent with the findings in HaCaT and 1205Lu
cells, efficient SMAD3 nuclear translocation was also observed
in fibroblasts treated with TGF-b, whether at low or high cell
density (Figure S2B).
In EpH4 cells, however, while TAZ was efficiently excluded
from the cell nucleus at high density, SMAD3 nuclear accumula-
tion only occurred in sparse cell cultures treated with TGF-b, not
in confluent cells (Figures 2C and S2A). These data are consis-
tent with the absence of SMAD3 phosphorylation and target
gene activation observed in these cells at high density (see
Figure 1) and fit the established model of TGF-b/SMAD signal
transduction whereby an absence of SMAD3 phosphorylation
precludes subsequent downstream signaling (reviewed in Mas-
sague´, 2012). They are, however, at odds with the model
whereby active (phosphorylated) SMAD complexes are seques-
tered in the cytoplasm by P-TAZ in confluent cells (Varelas et al.,
2010).
The Extent of TGF-b Signaling Does Not Rely upon
Cellular TAZ—and YAP—Levels
It has been suggested previously that TAZ levels regulate the
extent of TGF-b signaling (Varelas et al., 2008). Our data pre-
sented above do not fit this model because SMADs and TAZ
localization in either the cytoplasm or nucleus of cells appear
to be under distinct regulatory control mechanisms. In that these
findings significantly impact current models of TGF-b signaling,
the apparent lack of interference of Hippo pathway effectors
with SMAD nuclear translocation observed in keratinocytes
and melanoma cells (see Figures 2A and 2B) was further sub-
stantiated by simultaneous knockdown of TAZ and it paralog
YAP (Nallet-Staub et al., 2014). Despite a 95% reduction in
both TAZ and YAP protein levels (Figure S3A), there was no sig-
nificant alteration in the extent of TGF-b target gene induction, as
measured by qRT-PCR: induction of PAI-1 was essentially iden-
tical in control- and siYAP/TAZ-transfected cells (Figure S3B).
Last, to further confirm the independence of P-SMAD3 nuclear
translocation andHippo effectors, we took advantage of recently
established human melanoma cell lines in which stable TAZ
knockdown was obtained by lentiviral delivery of a specific
shRNA directed against TAZ (Nallet-Staub et al., 2014). These
cell lines fit the purpose of these experiments as they express
much higher levels of TAZ than YAP1/2 (Nallet-Staub et al.,
2014). TAZ knockdown in 1205Lu melanoma cells had no effect
on TGF-b-induced SMAD3 nuclear accumulation (Figure S3C)
target gene responses (Figure S3D), and induction of SMAD3/
4-specific transcription measured in transient cell transfection
assays with the (CAGA)9-MLP-luc reporter (Figure S3E). Like-
wise, in the WM852 melanoma line, knocking down TAZ
did not attenuate the induction of GLI2, PAI-1, CTGF, and
SMAD7 by TGF-b (Figure S3F), nor did it impact TGF-b-driven
SMAD3/4-specific transcription in SKmel28 melanoma cells
(Figure S3G).DevelHippo pathway activation upon cell density sensing is a wide-
spread phenomenon affecting a variety of cell types (reviewed in
Zhao et al., 2010). Yet, we found no evidence that it might inter-
fere with SMAD nuclear accumulation in response to TGF-b as
(a), altering endogenous levels of YAP/TAZ did not attenuate
TGF-b responses (Figure S3) and (b), in TGF-b-responsive cells,
TGF-b-driven nuclear accumulation of SMAD2/3 occurred under
conditions that excluded TAZ from the nucleus (e.g., dense cell
cultures; Figure 2). Specifically, out of the six cell lines tested,
only Eph4 cells lost TGF-b responsiveness at high cell density.
Moreover, this appeared to be due to a lack of SMAD3 phos-
phorylation, the primary event downstream of TGF-b receptors
that initiates the signaling cascade, not to cytoplasmic retention
of active SMAD complexes.
Loss of TGF-b Responsiveness in Polarized Epithelial
Cells Is Restricted to Their Apical Side
Since EpH4 cells similarly exhibited density-dependent Hippo
pathway activation, measured as nuclear exclusion of TAZ, yet
uniquely lacked P-SMAD nuclear accumulation in response to
TGF-b, we hypothesized that this cell-type specificity might be
associated with their capacity to establish baso-apical polarity
when grown at high density. To determine whether loss of TGF-
b responsiveness due to lack of SMAD3 phosphorylation at
high cell density is due to the establishment of cell polarity and/or
specific alterations of TGF-b receptor localization, we performed
parallel examination of TGF-b responses in EpH4, MDCK, and
AKR-2B cells. Both EpH4 and MDCK cells are of epithelial origin
and differ from the latter fibroblast cultures by their distinct baso-
apical polarized phenotype at high culture density. In a first set of
experiments, monolayer cultures at low and high density were
compared for SMAD3 phosphorylation in response to TGF-b.
As shown in Figure 3A, a 30-min stimulation with TGF-b resulted
in efficient SMAD3 phosphorylation in all three cell lines at low
density while in dense cultures, significant SMAD3 phosphoryla-
tion was solely observed in the AKR-2B fibroblasts, consistent
with the EpH4 results presented in Figure 1.
Because biochemical assays dependent upon cell density in
tissue culture plates are highly sensitive to any disruption of
the confluent monolayer, confluent AKR-2B, EpH4, and MDCK
cells in Transwell cultures were stimulated with TGF-b from
either the apical or basal reservoir, then assessed for SMAD3
phosphorylation. A schematic of the Transwell culture system
is provided in Figure 3B. In AKR-2B fibroblasts, TGF-b induced
SMAD3 phosphorylation from either reservoir (Figure 3B, left up-
per image, lanes 3 and 4). On the other hand, EpH4 and MDCK
cells showed domain-specific responses, with an absence of
SMAD3 phosphorylation when exposed to TGF-b on their apical
side while phosphorylation was high when TGF-b was added to
the basolateral (BL) compartment (Figure 3B, middle and bottom
left images, compare lane 3 [apical stimulation] with lane 4 [BL
stimulation]). Thus, at high density in Transwell cultures dishes,
non-polarized cells like AKR-2B fibroblasts maintain intact
TGF-b signaling whereas polarized cells exhibit domain-specific
SMAD3 phosphorylation. Loss of apical TGF-b responsiveness
in Transwell cultures is reminiscent of what is observed in
confluent monolayer epithelial cultures whereby TGF-b is essen-
tially delivered apically to the cells (see schematic diagrams in
Figures 3A and 3B).opmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevier Inc. 643
Figure 3. Plasma Membrane Domains
Control Cell- and Density-Specific TGF-b
Responsiveness
(A) Western analysis of P-SMAD3 (left) and SMAD3
(right) levels in AKR-2B fibroblasts, EpH4, and
MDCK epithelial cells grown at low (LD) or high
(HD) density monolayer cultures (schematic)
following a 60 min TGF-b stimulation.
(B) AKR-2B, MDCK, and EpH4 cells were grown in
monolayer (at LD) or Transwell cultures (sche-
matic). P-SMAD3 (left) and SMAD3 levels (right)
were determined by western blotting in monolayer
cultures following 60 min stimulation in the
absence () or presence (+) of TGF-b or subse-
quent to Transwell apical (AP) or basolateral (BL)
TGF-b addition.
(C) Confluent monolayers of EpH4 cells were
transduced with either TAT-Smad3 (left) or TAT-
Smad3P (right). Forty-five minutes later, cells were
fixed and subcellular localization of TAT-Smad3
and TAT-Smad3P was assessed by confocal mi-
croscopy. Representative results are shown.
Nuclei (blue) were stained with DAPI.
(D) Immunofluorescent detection of SMAD3 in
polarized EpH4 cells by confocal microscopy
following a 60 min incubation with TGF-b added
either to the apical (AP, left) or basolateral (BL,
right) Transwell chamber.To directly address the issue of whether active SMAD com-
plexes may be sequestered in the cytoplasm of confluent mono-
layer cultures of EpH4 cells, we took advantage of TAT-fusion
cell-penetrating peptide technology and generated cell-perme-
able TAT-SMAD3 protein. Specifically, confluent monolayers of
EpH4 cells were transduced with TAT-SMAD3, subjected or
not to in vitro phosphorylation by activated TbRI (see Experi-
mental Procedures). As shown in Figure 3C, while TAT-SMAD3
was almost exclusively localized in the cytoplasm (left image,
nucleo/cytoplasmic ratio of 0.3 ± 0.05), a large portion of TAT-
SMAD3P proteins directly accumulated in the nucleus of cells
(right image, nucleo/cytoplasmic ratio of 1.8 ± 0.1), directly es-
tablishing that SMAD3 phosphorylation is sufficient for its nu-
clear accumulation. In another set of experiments, polarized
EpH4 cells in Transwell cultures were treated with TGF-b added
apically or basolaterally. Remarkably, efficient SMAD3 nuclear
accumulation in response to TGF-b was exclusively observed
when the latter was delivered basolaterally, not apically (Fig-
ure 3D, nucleo/cytoplasmic ratios of 5.5 ± 0.2 versus 0.4 ± 0.1,
respectively). Thus, in these two complementary approaches,
there was minimal cytoplasmic retention of P-SMAD3 in
response to high cell density, because SMAD3 phosphorylation
was always associated with nuclear accumulation. These data
indicate that loss of apical TGF-b responsiveness in confluent
EpH4 cells is due to lack of SMAD3 phosphorylation, not to cyto-
plasmic sequestration of P-SMAD3, as initially proposed (Vare-
las et al., 2010).
Loss of Apical TGF-b Responsiveness in Polarized
Epithelial Cells Reflects Exclusive Basolateral TGF-b
Receptor Expression
The aforementioned lack of SMAD3 phosphorylation in polarized
cells exposed apically to TGF-bmay reflect either an absence of644 Developmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevierreceptors at the apical surface, or an inability of such receptors
to couple with the signaling machinery. In initial experiments to
analyze the dynamics of TbR localization as a function of cell
density, AKR-2B, EpH4, and MDCK cells were grown as low-
and high-density monolayer cultures and transiently transfected
with tagged TbRI or TbRII expression vectors. Their respective
cellular localization was analyzed by confocal microscopy. As
shown in Figure 4A (upper image), no defined polarity was
observed for either TbRI or TbRII in low density (LD) cultures
and there was no difference in their expression pattern between
fibroblasts and epithelial cells. In contrast, at high cell density
(HD, Figure 4A, lower image), whereas no changes in receptor
localization were observed for AKR-2B fibroblasts, both recep-
tors showed a strict basolateral expression in EpH4 and MDCK
epithelial cells. The same experiments performed in Transwell
culture dishes with EpH4 cells at high density refined the data,
with an exclusive localization of both TbRI and TbRII on the baso-
lateral sides of EpH4 cells when cell-cell contacts are estab-
lished (Figure 4B).
To validate these transient transfection findings, we next per-
formed surface biotinylation assays and examined endogenous
TbRI and TbRII in AKR-2B, EpH4, and MDCK cells grown as
monolayers at low or high density. These experiments revealed
a dramatic reduction in TbRI and TbRII expression levels at the
surface of EpH4 and MDCK cells, not in AKR-2B fibroblasts, at
high versus low density (Figure 4C), consistent with the data
from Figure 3A. These results explain the dramatic drop in
SMAD3 phosphorylation specifically observed in confluent
EpH4 cells in response to TGF-b (Figures 1C and 3A). TbRI and
TbRII levels inAKR-2Bfibroblasts remained relatively unchanged,
irrespective of culture density (Figure 4C). Similar assays were
next performed using EpH4 andMDCK cells grown in Transwells
to promote their polarization. Polarity of the epithelial sheetsInc.
Figure 4. Loss of Apical TGF-b Responsive-
ness in Polarized Epithelial Cells Reflects
Exclusive Basolateral TGF-b Receptor
Expression
(A) IF detection of transiently transfected Myc-
TbRI and HA-TbRII in low density (LD, upper) and
high density (HD, lower) monolayer cultures of
AKR-2B, MDCK, and EpH4 cells. Images are
represented as XZ cross-sections of transfected
cells.
(B) IF detection of transiently transfected Myc-
TbRI and HA-TbRII in polarized Transwell cultures
of EpH4 cells. Two representative XZ cross-sec-
tions of transfected cells are shown. Nuclei (blue)
were stained with DAPI.
(C) Surface biotinylation assays of endogenous
TbRI and TbRII in AKR-2B, EpH4, and MDCK
cells grown in low- or high-density monolayer
cultures.
(D) Apical (AP) and basolateral (BL) surface bio-
tinylation assays of endogenous TbRI and TbRII
in MDCK and EpH4 cells in monolayer (low-
density) or Transwell cultures (high density,
polarized). Cell proteins were biotinylated either
from the medium (monolayer on plastic, low
density) or from the apical or basolateral medium
in the case of high density polarized transwell
cultures. After surface biotinylation, proteins were
immunoprecipitated with streptavidin-agarose
and then detected by blotting with the appropriate TGF-b receptor or E cadherin antibody. Lanes C and T reflect immunoprecipitated protein in the absence
of biotinylation (C) or in monolayer for total labeling (T), respectively. E-cadherin was detected to serve as a marker of basolateral cell surfaces.
(E) Quantitative reverse transcriptase–PCR analysis of JUNB, CTGF, and SMAD7 expression in polarized EpH4 cells incubated without () or with TGF-b (2 hr)
added either in the apical (AP) or basolateral (BL) compartment of Transwells. Results are expressed as -fold induction by TGF-b and are the mean ± SD from
two independent experiments, each measured in triplicate.formed by EpH4 andMDCK cells was verifiedwith an inulin assay
that indicated an absence of apical to basolateral flux in these
cells, as opposed to what is observed in confluent fibroblasts un-
der the same culture conditions (see Figure S4). Remarkably, un-
like cells grown as low-density monolayers (T), neither EpH4 (left
image) nor MDCK (right image) cells polarized in Transwell cul-
tures expressed TbRI or TbRII on their apical (AP) surface (Fig-
ure 4D), only on their basolateral (BL) sides, in agreement with
previous observations from us and others using various cell
models (Murphy et al., 2004, 2007; Yakovich et al., 2010; Snod-
grass et al., 2013). Consistent with SMAD3 phosphorylation and
TbR localization data shown above, apically delivered TGF-b
(AP) had little capacity to induce JUNB, CTGF, or SMAD7 gene
expression inpolarizedEpH4cells, contrastingwith the solid tran-
scriptional response that we observedwhen TGF-bwas added to
the BL compartment (Figure 4E).
As seen from the experiments above, a major discrepancy ex-
ists between the published data by Varelas et al. (2010), who
observed SMAD3 phosphorylation in dense, polarized EpH4
cell monolayer cultures, without subsequent nuclear SMAD
complex accumulation (Varelas et al., 2010) and ours. Specif-
ically, our data suggest that lack of downstream signaling results
from an absence of apical TGF-b receptors and subsequent
SMAD3 phosphorylation in polarized EpH4 cells, not YAP/TAZ
driven SMAD3 cytoplasmic sequestration. Although all these ex-
periments were performed under conditions that closely fol-
lowed those described in (Varelas et al., 2010; TGF-b stimulation
48 hr/60 hr after plating at a density of 250,000cells/well in 24-Develwell plates), it was possible that these divergent conclusions
might result from discrete differences in experimental conditions
whereby their data may have been obtained when cells were at
an intermediate/early stage of cell polarization whereas ours
are fully polarized. To address that issue, kinetic experiments
were performed that combined parallel examination of TbRI,
TbRII, and E-cadherin surface expression, together with the ca-
pacity of TGF-b to induce both SMAD3 phosphorylation and
target gene induction at various time points following cell seed-
ing. EpH4 cells were seeded at a density equivalent to that of
250,000cells/24-well plate in monolayer cultures and TbRI,
TbRII, and E-cadherin levels were determined at 8, 24, 48, and
72 hr post-plating by surface biotinylation assays. This approach
thus allows a determination of the amount of receptors available
for apically delivered TGF-b over the course of cell polarization.
As shown in Figure 5A, surface expression of both TbRI and
TbRII was maximal at the 8-hr time-point, slightly decreased
24 hr after plating, and was absent from the cell surface at
both 48 and 72 hr after cell seeding (Figures 4C and 4D). Remark-
ably, E-cadherin in the same samples was detectable up to 48 hr,
indicating that in EpH4 cells, TGF-b receptors relocalize basolat-
erally faster than E-cadherin does. In other words, TbRs disap-
pear from the apical cell surface before cells achieve full polarity.
Phosphorylation of SMAD3 in response to TGF-b and induction
of target gene expression (JUNB, CTGF, and SMAD7) followed
the same pattern observed for TbR surface expression: both
were maximal at both 8 and 24 hr after cell seeding, and largely
attenuated at the later time points (Figures 5B and 5C,opmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevier Inc. 645
Figure 5. TbR Basolateral Relocalization
during EpH4 Cell Polarization: Implication
for TGF-b Signaling
EpH4 mouse mammary epithelial cells were grown
in high-density conditions (see Experimental Pro-
cedures).
(A) Surface biotinylation assays of endogenous
TbRI, TbRII, and E-cadherin performed at various
time points following cell seeding. One of two ex-
periments with similar results is shown.
(B) Western analysis of P-SMAD3 levels following a
2-hr TGF-b stimulation at various time points
following cell seeding. Upper panel: representative
blot from one of five experiments that gave similar
results. Lower: Densitometric analysis of P-
SMAD3 levels. Results are expressed as -fold in-
duction by TGF-b at each time-point.
(C) Quantitative reverse transcriptase–PCR anal-
ysis of JUNB, CTGF, and SMAD7 expression in
EpH4 cells incubated without () or 2 hr with (+)
TGF-b at various time points following cell seeding.
Results, expressed as -fold induction by TGF-b
at each time point are the mean ± SD from
five independent experiments, each measured in
triplicate.respectively). This is consistent with the data presented in Fig-
ures 3 and 4 obtained 48 hr after cell plating. Thus, these kinetic
experiments did not identify a time-point following TGF-b recep-
tor binding whereby SMAD3 phosphorylation would occur while
downstream events would be blunted in response to cell density
driven Hippo activation, as reported by Varelas et al. (2010).
Rather, they support our experiments described above that
TGF-b-induced SMAD3 phosphorylation is followed by nuclear
accumulation of activated SMAD complexes and subsequent
target gene activation. The absence of apical TGF-b signaling
in polarized cells, as is observed at 48 hr after cell plating, re-
flects the basolateral relocalization of TGF-b receptors that takes
place during the establishment of polarity.
Disruption of Cell-Cell Contacts in Polarized EpH4 Cells
byCa2+ Depletion Restores SMAD3Phosphorylation and
Downstream Target Gene Activation in Response to
Apically Delivered TGF-b
Polarized epithelial cells establish cell-cell contacts that include
Ca2+-dependent tight and adherens junctions. These junctions
prevent intercellular diffusion of large molecules and thus, are
likely to prevent apically delivered TGF-b from binding its baso-
lateral receptors. To test this hypothesis and further confirm the
dissociation of density per se, and SMAD3 signaling, we as-
sessed whether disruption of these junctions may be sufficient
to restore SMAD3 phosphorylation upon apical TGF-b delivery.
As shown in Figure 6A, Ca2+ depletion had no effect on TGF-
b-induced SMAD3 phosphorylation in sparse EpH4 cultures
(LD). On the other hand, disruption of cell-cell contacts from
confluent EpH4 cells (HD) by Ca2+ depletion restored SMAD3
phosphorylation in response to ‘‘apically delivered’’ TGF-b.
These data establish that cell-cell contacts in polarized epithelial646 Developmental Cell 32, 640–651, March 9, 2015 ª2015 Elseviercells control the access of apically available TGF-b ligands to ba-
solateral TbRs. We next tested whether Ca2+ depletion could
also restore efficient TGF-b-induced target gene expression in
confluent EpH4 cells. As shown in Figure 6B, consistent with
the data from Figure 1, confluent EpH4 cells in Ca2+-containing
culture conditions exhibited very weak activation of target genes
(e.g., 2- to 3-fold). A 30-min Ca2+ depletion, however, was suffi-
cient to allow solid transcriptional responses, as evidenced by
induction of JUNB,CTGF, and SMAD7 10- to 25-fold above con-
trol values. Given the basolateral localization of TbRs in confluent
EpH4 cells (see Figures 4A–4D), these data suggest that disrup-
tion of Ca2+-dependent cell-cell contacts allows paracellular
diffusion of apically delivered TGF-b to activate signaling.
DISCUSSION
In summary, we have confirmed previous observations that Hip-
po pathway activation occurs as a result of cell density sensing
(Zhao et al., 2007), and demonstrated that it occurs in a wide va-
riety of cell types, irrespective of their lineage. Second, we have
demonstrated that most cell types exhibit functional TGF-b
signaling, whether they are at low or high cell density, consistent
with a large body of literature. Our data also document that
SMAD nuclear accumulation in response to TGF-b is indepen-
dent from YAP/TAZ levels. Most importantly, we demonstrate
that density-driven loss of TGF-b responsiveness is exclusively
observed in polarized epithelial cells and reflects the establish-
ment of Ca2+-dependent cell-cell contacts that prevent ligand
binding to, and activation of, basolaterally expressed TGF-b
receptors. This, in turn, prevents SMAD phosphorylation, subse-
quent nuclear accumulation, and gene responses. A model de-
picting these findings is shown in Figure 7.Inc.
Figure 6. Effect of Ca2+ Depletion on TGF-b Response in High-Den-
sity Monolayer Cultures of EpH4 Cells
(A) Western analysis of P-SMAD3 levels in EpH4 cells treated without () or
with (+) TGF-b for 30 min at low (LD) or high (HD) density in monolayer cultures
in the presence (+) or absence () of Ca2+.
(B) Quantitative reverse transcriptase–PCR analysis of JUNB, CTGF, and
SMAD7 expression in confluent monolayers of EpH4 cells incubated without
() or with (+) TGF-b (2 hr) in medium with (+) or depleted of () Ca2+. Results
are expressed as -fold induction by TGF-b and are the mean ± SD from two
independent experiments, each measured in triplicate.
Low density 








Figure 7. Schematic Summary of TAZ and SMAD3 Nucleo-Cyto-
plasmic Shuttling in Response to Cell Density or TGF-b Stimulation
in Non-Polarized or Polarized Cells at Low or High Density
At low density (LD), TAZ (red) is nuclear and SMAD3 (green) is cytoplasmic.
TGF-b receptors are distributed throughout the cell surface. In response to
TGF-b, SMAD3 accumulates in the nucleus where TAZ is located. At high
density (HD), TAZ is excluded from the nucleus, as a result of cell density
sensing. In non-polarized cells, TGF-b induces SMAD3 nuclear accumulation,
while TAZ remains cytoplasmic. In polarized cells (schematically represented
with apical villi), apical delivery of TGF-b is without effect on SMAD localization
because TbRs are exclusively basolateral and TGF-b access to its receptors is
blocked by intercellular junctions.These data are at odds with some of those from a previous
report that concluded that activated SMAD complexes are
sequestered in the cytoplasm by P-TAZ (Varelas et al., 2010).
In the latter report, the authors gave priority to their finding of a
physical interaction between TAZ and SMAD3. Several conclu-
sions were then drawn. For example, Ca2+ depletion was found
to both drive TAZ nuclear accumulation and restore TGF-b
signaling. It is well established that Ca2+ is required for the integ-
rity of epithelial cell contacts, which themselves directly control
TAZ nucleo-cytoplasmic localization (Chen et al., 2010; Robin-
son et al., 2010; Zhao et al., 2007). Thus, while we agree with
both observations, we believe that the occurrence of the two
phenomena is temporally parallel but mechanistically indepen-
dent. Given the relatively similar levels of expression of YAP/
TAZ (and SMADs) in all cell types, if P-YAP/TAZ were to retain
P-SMADs in the cytoplasm, this phenomenon would be rather
widespread across various cell types, irrespective of polariza-
tion, because cell-cell contact-driven YAP/TAZ nuclear exclu-
sion seems to be a general phenomenon not restricted to polar-
ized cells. This is not the case, as attested by the plethora of data
published using confluent cells to study TGF-b responses (see
examples and corresponding references in the Introduction)Develand by our demonstration that (a) cell-permeable TAT-PSMAD3
accumulates in the nucleus of confluent transduced EpH4 cells
while TAT-SMAD3 does not (Figure 3C), and (b) basolateral stim-
ulation of polarized cells with TGF-b not only leads to phosphor-
ylation, but also to rapid nuclear accumulation of SMAD3 and
subsequent target gene transcription (Figures 3B, 3D, and 4E),
indicating that phosphorylation of SMAD3 is sufficient to initiate
the process of its nuclear translocation.
Physical interactionsbetweenYAP/TAZandSMADshavebeen
studied by various groups. While we originally identified a direct
YAP/SMAD7 interaction (Ferrigno et al., 2002), a few research
groups have focused their attention on the interactions between
YAP/TAZ and receptor-associated SMADs. Massague´’s group
showed in immunoprecipitation experiments of overexpressed
proteins that YAP interacts strongly with SMAD1, which allows
for an enhancement of BMP-dependent transcription, while
weakly interacting with SMAD3 (Alarco´n et al., 2009). This was
confirmed by another study with tagged proteins that showed
weakaffinity of YAP forSMAD3ascompared toSMAD1, yet iden-
tified a large transcriptional complex comprising YAP, SMAD3,
TEAD, and p300 involved in the upregulation of a subset of
TGF-b target genes including CTGF (Fujii et al., 2012). Likewise,
in human embryonic stem cells, TGF-b was recently found to re-
cruit SMAD2/3 to TEAD/YAP/TAZ complexes in association withopmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevier Inc. 647
OCT4, contributing to the regulationof pluripotency genes (Beyer
et al., 2013). The latter have been shown independently to be
targets for the p300/CBP-interacting protein (p/CIP), which is
required for transcriptional activity of various CBP/p300-depen-
dent transcription factors (Chitilian et al., 2014). These data are
consistent with the demonstration that external signaling and
the core transcriptional machinery form tightly integrated regu-
latory networks in embryonic stem cells (Chen et al., 2008).
Altogether, it would appear that cooperation between YAP/
TAZ and SMAD3 to regulate a subset of TGF-b target genes
primarily reflects a nuclear action linked to their shared capac-
ity to bind CBP/p300. Similarly, a recent paper by Varelas’
group reported that nuclear YAP/TAZ and SMAD2/3/4 drive in-
vasion and metastasis via shared p300-dependent mechanisms
(Hiemer et al., 2014). On the other hand, they concluded that
when the Hippo pathway is active (i.e., YAP/TAZ are cyto-
plasmic), TGF-b-driven tumor suppression and cytostasis oc-
curs via SMAD2/3/4-driven transcription independent of YAP/
TAZ, consistent with our data presented herein.
A critical difference between the works from Wrana’s group
(Varelas et al., 2008, 2010) and ours resides in the determination
of early events regulating TGF-b signaling in relation to cell den-
sity. We identify a defect in SMAD3 phosphorylation due to TGF-
b receptor localization to basolateral membranes, exclusively in
dense polarizable cell lines such as EpH4 or MDCK cells, which
then lack downstream TGF-b signaling and gene responses.
Surface biotinylation experiments aimed at defining the kinetics
of receptor basolateral relocalization during establishment of po-
larity showed that TbRs disappear from the apical surface of
EpH4 cells more rapidly than E-cadherin, suggesting that they
establish basolateral domain localization before cells have fully
established adherens junctions (i.e., are not fully polarized). In
these experiments, target gene transcription in response to api-
cal TGF-b occurred at all time points when SMAD3 was phos-
phorylated (in other words, when TbRs were still available on
the apical surface). We were unable to define a time in the polar-
ization process whereby high density, per se, could have re-
sulted in the cytoplasmic sequestration of P-SMAD complexes.
While our findings are fully consistent with previously published
observations (Murphy et al., 2004, 2007) of basolateral posi-
tioning of TbRs in polarized epithelial cells, we also provide evi-
dence for the restriction of this process to polarized cells
because fibroblasts do not undergo any domain-specific reorga-
nization of cell surface receptors in relation to cell density. This
may be particularly important as in some models polarized
epithelial cells secrete TGF-b ligands from their apical side (Mur-
phy et al., 2004) and luminal TGF-b is commonly observed. As
such, it is highly plausible that expression of TGF-b receptors
restricted to the basolateral compartment may allow Ca2+-
dependent cellular junctions, tight and/or adherens, to provide
polarized epithelia with a resistance mechanism against TGF-
b-induced EMT by preventing TGF-b binding to its receptors.
This, in turn, would maintain epithelial integrity and organ func-
tion. Loss of polarity, as seen during early carcinogenesis may
accelerate TGF-b-induced EMT, leading to cell dissociation
and metastatic dissemination. Further experiments will be
needed to verify these hypotheses.
To conclude, we have uncovered cell-type specific regulation
of TGF-b responses by cell density, whereby epithelial cells with648 Developmental Cell 32, 640–651, March 9, 2015 ª2015 Elsevierbasoapical polarity exhibit strict and exquisite density-depen-
dent redistribution of TbRs to their basolateral sides, an event
that precludes TGF-b responsiveness from their apical compart-
ment. This phenomenon appears to be specific for polarized
epithelial cells, as fibroblasts grown to confluency did not
undergo any detectable repositioning of TbRs on their cell sur-
face. We also provide evidence that TAZ nuclear exclusion
induced by cell-cell contacts is ubiquitous and that mechanisms
driving nucleo-cytoplasmic localization of TAZ and P-SMAD are
independent, eventually leading to situations whereby both
proteins are fortuitously localized in the same cellular compart-




Human lung WI26 and mouse embryonic AKR-2B fibroblasts, immortalized
human HaCaT keratinocytes and mouse EpH4 breast epithelial cells, human
MDA-MB-231 breast carcinoma cells, canine MDCK kidney epithelial cells,
and human PANC-1 pancreatic carcinoma cell lines were maintained in
DMEM supplemented with 10% fetal bovine serum (FBS). Human 1205Lu,
WM852, and SKmel28 melanoma cell lines (Alexaki et al., 2008, 2010; Jave-
laud et al., 2007, 2011a; Rodeck et al., 1999) were grown in RPMI 1640 (Invi-
trogen) supplemented with 10% FBS. For experiments on monolayer cultures,
cells were plated at low or high density, 25,000 cells or 250,000 cells in 24-well
dishes or proportionally in accordance to dish surface. Twenty-four hours
later, medium was replaced to reduce FBS concentration to 1%. TGF-b treat-
ment (30 min to 2 hr, depending on endpoint) was performed either the next
day or 4 hr later in the case of kinetic experiments. For Transwell cultures
(0.4-mm Costar polycarbonate membranes), cells were plated at a density of
5 3 104 cells/ml in 0.5 ml of culture medium and grown for 3 days prior to ex-
periments. Fully polarized monolayers of MDCK and EpH4 cells were obtained
after 3 days, as verified by serial measurements of trans-epithelial resistance
with a Millipore EMR2 device, consistent with our previous work (Murphy
et al., 2004, 2007; Yin et al., 2013).
Cell-Permeable TAT-Smad3 and Tat-Smad3P Protein Transduction
and Detection
TAT-Smad3 or TAT-Smad3P proteins (see Supplemental Experimental Proce-
dures) containing an amino terminal HA epitope tagwere added to high density
monolayer cultures of EpH4 cells at 37C for 45 min. Cells were then fixed in
4% paraformaldehyde, permeabilized with 0.1%Triton X-100, and blocked
by goat serum. TAT-Smad3 and TAT-Smad3P were detected with an anti-
HA primary antibody (Cell Signaling) and Cy3-conjugated secondary antibody
(Jackson ImmunoResearch Laboratories).
RNA Extraction and Gene Expression Analysis by qRT-PCR
RNA extraction and quantitative RT-PCR using the SYBR Green technology
have been described previously (Javelaud et al., 2011b; Mohammad et al.,
2011). For experiments comparing TGF-b in low- (LD) versus high-density
(HD) cultures, cells were seeded at a ratio of 1 to 10 between LD and HD,
with cell numbers in HD conditions determined in prior experiments to be suf-
ficient for cell confluency immediately after cell attachment. TGF-b treatment
was done 24 hr after cell seeding and luciferase activity was measured 16 hr
later. Experiments were performed in triplicate to validate gene expression
data in each cell line. Primers used are listed in the Supplemental Experimental
Procedures.
Cell Transfections
For reporter assays, cells in monolayer cultures were transfected with the pol-
ycationic compound FuGENE (Roche Diagnostics) at 70% to 80% confluency
in fresh medium with 200 ng of the SMAD3/4-specific firefly luciferase reporter
construct (CAGA)9-MLP-luc (Dennler et al., 1998) and 50 ng of Renilla lucif-
erase expression vector to estimate transfection efficiencies. For experiments
comparing TGF-b in LD versus HD cultures, transfections were performed inInc.
10 cm diameter dishes. Cells were split the next day and seeded at a ratio of 1
to 10 between LD and HD. TGF-b treatment was done 24 hr after cell seeding
and luciferase was measured 16 hr later. Transient transfection of fully polar-
ized EpH4 cell monolayers in 12-mm Transwells was performed on day 3 after
plating, using Lipofectamine 2000 according to the manufacturer’s instruc-
tions (Invitrogen). Details of the procedure and description of the Myc-tagged
TbRI expression vector used for confocal microscopy experiments may be
found in (Murphy et al., 2004). HA-tagged TbRII expression vector was a gift
from Dr. Jeffrey Wrana (University of Toronto, Ontario). Luciferase activities
were determined with a Dual-Glo luciferase assay kit (Promega) using a Fluo-
roskan Ascent FL (Thermo Labsystems). All experiments were performed at
least three times.
For transient gene silencing, HaCaT cells were transfected with two distinct
siRNAs specifically targeting YAP or TAZ (Sigma-Aldrich human YAP or TAZ
Mission siRNAs SASI_Hs01_00182403 and SASI_Hs01_00124479, respec-
tively). The siRNA sequences were different from those from the shRNA lenti-
viral vectors. Sequence details may be found in (Nallet-Staub et al., 2014). A
non-targeting siRNA (Sigma-Aldrich Mission Universal Negative control siRNA
#2) was used as control. For experiments requiring RNA or protein extraction,
cells were seeded at 23 105 cells/well in six-well plates and transfected 24 hr
later in fresh medium containing 1% fetal calf serum (FCS) with siRNA (150 ng/
well) using 12 ml of HiPerfect reagent. Sample processing occurred 48 hr later.
Stable TAZ knockdown in melanoma cell lines has been described previously
(Nallet-Staub et al., 2014).
Biotinylation of Cell Surface Receptors
Briefly, freshly made sulfo-NHS-SS biotin/HBSS (1 mg/ml; Thermo Scientific)
was added to either a monolayer culture in a six-well plate (1 ml) to assess
total (T) labeling, or domain-specific receptor expression was determined
by sulfo-NHS-SS biotin/HBSS addition to either the apical (0.5 ml) or baso-
lateral (1 ml) reservoirs of Transwell dishes. Biotin-bound proteins were
pulled down with Streptavidin-agarose and resolved on 10% SDS-PAGE.
TbRI and TbRII levels were examined with western blotting. Details may be
found in (Yin et al., 2013).
Western Blotting
Whole cell extracts and procedures for western analyses have been described
previously (Alexaki et al., 2010; Dennler et al., 2009; Yin et al., 2013). For exper-
iments comparing SMAD3 phosphorylation in response to TGF-b in LD versus
HD cultures, cells were seeded at a ratio of 1 to 10 between LD and HD, with
cell numbers in HD conditions determined in prior experiments to be sufficient
for cell confluency immediately after cell attachment. TGF-b treatment was
done 24 hr after cell seeding and proteins extracted 30 min later. Antibody de-
scriptions, references, and dilutions are provided in the Supplemental Exper-
imental Procedures.
Immunofluorescence
Cells grown on poly-lysine-coated coverslips were fixed with 4% paraformal-
dehyde for 10 min and permeabilized with 13 PBS, 0.1% Triton X-100, 5%
FCS for 1 hr at room temperature then blocked with goat serum. Cells were
then incubated overnight at 4C with primary antibodies raised against
SMAD2/3 or TAZ (see Supplemental Experimental Procedures for details).
Nuclei were stained with Hoechst 37342 (1:1,000, Sigma-Aldrich). After
washing with PBS, appropriate Alexa Fluor (Life Technologies) anti-goat
(488), anti-rabbit (555), or anti-mouse (467) fluorescent secondary antibodies
(1:1,000) were used for immunofluorescent visualization using either an in-
verted fluorescent microscope (Leica DM-IRB, Leica Microsystems) equip-
ped with a digital video camera (Princeton Instruments), or with a 1003
objective on a Zeiss LSM 510 confocal system. Image capture was per-
formed using MetaMorph software version 7.7 (Molecular Devices). Fluores-
cence signals were analyzed and images merged using ImageJ software
tools.
Statistics
All quantitative data are expressed as mean ± SD. The p values for experi-
ments were obtained with the Mann-Whitney U-test. Differences between
groups were considered significant for p% 0.05. **p < 0.01; ***p < 0.001.DevelSUPPLEMENTAL INFORMATION
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